Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers March 20, 2019
Pharmacy Choice - News - Drug Delivery Systems - March 20, 2019

Pharmacy News

 Drug Delivery Systems
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

12/31/18 - Adamis Pharmaceuticals Submits New Drug Application to FDA for Its Naloxone Pre-Filled Syringe
Adamis Pharmaceuticals Corporation today announced the submission of a New Drug Application to the U.S. Food and Drug Administration for its naloxone pre-filled single dose syringe product candidate. This injection is designed for the treatment of an opioid overdose. Dennis J. Carlo, President and CEO of Adamis, stated, This NDA submission rep
12/31/18 - Adamis Pharmaceuticals Submits New Drug Application to FDA for Its Tadalafil Sublingual Tablet
SAN DIEGO- Adamis Pharmaceuticals Corporation today announced the submission of a New Drug Application to the U.S. Food and Drug Administration for its fast-dissolving sublingual tadalafil tablet. This product candidate is designed for the treatment of erectile dysfunction. Dennis J. Carlo, President and Chief Executive Officer of Adamis, stated,'
12/31/18 - FDA Grants Priority Review Designation for Heron Therapeutics' NDA for HTX-011, a Non-Opioid for Postoperative Pain Management
Heron Therapeutics, Inc., a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced that the U.S. Food and Drug Administration has accepted the new drug application for Heron's investigational agent, HTX-011,
12/31/18 - Health and Human Services Department (HHS); Food and Drug Administration (FDA) (F.R. Page 61642) - Meeting
EVENT: Health and Human Services Department; Food and Drug Administration holds a meeting of the Endocrinologic and Metabolic Drugs Advisory Committee to discuss new drug application 210934 for sotagliflozin oral tablet, sponsored by Sanofi-Aventis U.S. LLC, for the proposed indication: Adjunct to insulin therapy to improve glycemic control in adul
12/31/18 - Luye Pharma Announces Innovative Drug - Risperidone Extended Release Microspheres for Injection has Reached Final Stage of NDA Process
We expect LY03004 will be launched in the U.S. and China markets by the end of 2019. ". Moreover, registration of Rivastigmine single-day transdermal patch has already been accepted by National Medicine Products Administration in China. The registrations of above products are progressing well in strategic markets such as China, the U.S., Europe and
12/31/18 - Prevalence of asthma and its management: A review
Among respiratory problems, asthma is one of the most rapidly growing disorder which has victimised about one-third of the world s population and almost 2.5 million patients die annually as a result of severe exacerbation. Asthmatic patients most of the time fail to receive maximum benefits from the therapy because of drug-related problems, side
12/30/18 - Supply, installation and commissioning of bio-medical equipment for the department NET SKILLS LAB [TendersInfo (India)]
1 Advanced Cardiac Life Support Mannequin 2 Airway Management Trainer 3 Basic Life Support Adult Mannequin 4 ALS Infant Mannequin 5 Anatomical Torso Trauma Mannequin 6 Head Trauma Mannequin 7 Syringe Infusion Pump 8 Phlebotomy Trainer Arm 9 Infant Intraosseous Trainer 10 Central IV manikin with Internal Jugular, Subclavian& Femoral access 11 Ventil
12/29/18 - Adamis Pharmaceuticals Submits New Drug Application to FDA for Its Tadalafil Sublingual Tablet
Adamis Pharmaceuticals Corporation today announced the submission of a New Drug Application to the U.S. Food and Drug Administration for its fast-dissolving sublingual tadalafil tablet. This product candidate is designed for the treatment of erectile dysfunction. Dennis J. Carlo, President and Chief Executive Officer of Adamis, stated, The fil
12/29/18 - Opiant Pharmaceuticals Licenses Cannabinoid Overdose Therapy from Sanofi [Tehran Times (Iran)]
A study of national emergency room data conducted by Jay J. Shen, PhD, et al., published in the Journal of Addiction Medicine in October 2018, shows that over 0.51% of all emergency room visits are related to cannabis use. Santa Monica, California, based Opiant Pharmaceuticals, is developing medicines for addiction treatment and drug overdose.
12/28/18 - "Ketamine Transdermal Delivery System" in Patent Application Approval Process (USPTO 20180353437)
By a News Reporter-Staff News Editor at Biotech Week A patent application by the inventors Tang, Huadong; Tan, Hock S.; Mayersohn, Michael, filed on June 27, 2016, was made available online on December 13, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to Shenox P
12/28/18 - A Non-Randomized, Open Label, One Sequence, Two-Period Cross-Over Study to Investigate the Effect of CYP3A Inhibition on the Pharmacokinetics of RO7017773 in Healthy Participants
By a News Reporter-Staff News Editor at Pharma Business Week Staff editors report on the newly launched clinical trial, NCT03774576, which has the following summary description: "The purpose of this study is to investigate the effect of multiple oral doses of itraconazole on the pharmacokinetics of RO7017773 in healthy volunteers." As a matter of
12/28/18 - A Phase I, Double-Blind, Randomised, Parallel Group Study to Demonstrate the Equivalent Pharmacokinetic Properties of a Single Intravenous Dose of HD201 and EU-Herceptin and US-Herceptin in Healthy Male Subjects
By a News Reporter-Staff News Editor at Hepatitis Weekly Staff editors report on the newly launched clinical trial, NCT03776240, which has the following summary description: "The purpose of the study is to demonstrate demonstrate the pharmacokinetic similarity of HD201 to the European and American reference products Herceptin, following a single
12/28/18 - A summary of electrospun nanofibers as drug delivery system
By a News Reporter-Staff News Editor at Drug Week In recent studies, nanotechnology has proven to be an interesting approach towards solving problems in the field of medicine. Jose Manuel Cornejo Bravo demonstrates the use of electrospun polymeric nanofibers as an interesting method for drug delivery systems application. Dr Bravo's research prese
12/28/18 - A Two-Period, Open-label Trial Evaluating the Efficacy and Safety of Dasiglucagon for the Treatment of Children With Congenital Hyperinsulinism
By a News Reporter-Staff News Editor at Health& Medicine Week Staff editors report on the newly launched clinical trial, NCT03777176, which has the following summary description: "The objective of the trial is to evaluate the efficacy of dasiglucagon administered as a subcutaneous infusion in reducing hypoglycemia in children with CHI."
12/28/18 - Alkermes and Biogen Announce Submission of a New Drug Application to U.S. Food and Drug Administration for Diroximel Fumarate in Multiple Sclerosis
By a News Reporter-Staff News Editor at Pharma Business Week Alkermes plc and Biogen Inc. announced that Alkermes has submitted a New Drug Application to the U.S. Food and Drug Administration for diroximel fumarate, a novel oral fumarate in development for the treatment of relapsing forms of multiple sclerosis. Alkermes is seeking approval of dir
12/28/18 - Cerebral Oxygenation and Metabolism in Patients Undergoing Clipping of Cerebral Aneurysm: A Comparative Study Between Propofol-based Total Intravenous Anesthesia and Sevoflurane-based Inhalational Anesthesia
By a News Reporter-Staff News Editor at Clinical Trials Week Staff editors report on the newly launched clinical trial, NCT03778723, which has the following summary description: "Despite the theoretical benefits of i.v. agents, volatile agents remain popular. In a study comparing desflurane, isoflurane, and sevoflurane in a porcine model of intra
12/28/18 - Dr. Reddy's Laboratories announces the launch of Sevelamer Carbonate for Oral Suspension in the U.S. Market
Hyderabad- Dr. Reddy's Laboratories Ltd. today announced the launch of Sevelamer Carbonate for Oral Suspension, in 0.8 g and 2.4 g packets, a therapeutic equivalent generic version of Renvela for Oral Suspension, approved by the U.S. Food and Drug Administration. Dr. Reddy's Laboratories Ltd. is an integrated pharmaceutical company, committed to pr
12/28/18 - FDA Approves Inhaled Parkinson`s Drug Just Before Government Shutdown [Tehran Times (Iran)]
The US Food and Drug Administration approved levodopa inhalation powder as a first-of-its-kind intermittent therapy for off episodes in patients with PD currently being treated with carbidopa/levodopa. Drug maker Acorda Therapeutics received word of its approval on the evening of December 21 just prior to the government shutdown taking place at...
12/28/18 - Findings on Drug Delivery Systems Reported by Researchers at Fudan University (Strategies of Combination Drug Delivery for Immune Checkpoint Blockades)
According to news reporting out of Shanghai, People's Republic of China, by NewsRx editors, research stated, "The past few years have witnessed vast clinical accomplishments of immune checkpoint blockades, which block the regulatory receptor expressed on immune cells or tumor cells to prevent the suppression of antitumor cytotoxic T-cell responses.
12/28/18 - Habit-forming drugs reaching state via small courier firms [Governance, Risk & Compliance Monitor Worldwide]
Neither buprenorphine nor tramadol is manufactured in the state but in the last one year, the states Food and Drug Administration has made big seizures of these drugs in Ludhiana and Bathinda. In August, the states Food and Drug Administration had raided a wholesaler in Ludhiana and had seized 1.6 lakh tablets of buprenorphine plus nalexone from th
12/28/18 - Habit-forming drugs reaching state via small courier firms [Trends (Middle East)]
Neither buprenorphine nor tramadol is manufactured in the state but in the last one year, the states Food and Drug Administration has made big seizures of these drugs in Ludhiana and Bathinda. In August, the states Food and Drug Administration had raided a wholesaler in Ludhiana and had seized 1.6 lakh tablets of buprenorphine plus nalexone from th
12/28/18 - Hepatic Artery Infusion Chemotherapy Plus Programmed Cell Death Protein-1 (PD-1) Antibody vs Hepatic Artery Infusion Chemotherapy Plus Sorafenib for Advanced Hepatocellular Carcinoma
By a News Reporter-Staff News Editor at Clinical Trials Week Staff editors report on the newly launched clinical trial, NCT03780634, which has the following summary description: "The purpose of this study is to evaluate the efficacy and safety of hepatic artery infusion chemotherapy combined with Programmed Cell Death Protein-1 antibody compared
12/28/18 - Identification of Allergic Asthmatics Reactive to Felis Catus (Cat Hair) Allergen Inhalation
By a News Reporter-Staff News Editor at Clinical Trials Week Staff editors report on the newly launched clinical trial, NCT03780387, which has the following summary description: "This study is designed to identify Felis Catus, or cat hair, sensitive asthmatics who demonstrate a late phase asthmatic response after cat hair inhalation. These subjec
12/28/18 - Intravenous Human Umbilical-Cord-Derived Mesenchymal Stem Cells For Premature Infants At High Risk For Bronchopulmonary
By a News Reporter-Staff News Editor at Clinical Trials Week Staff editors report on the newly launched clinical trial, NCT03774537, which has the following summary description: "This study is an open-label, single-center, dose escalation study to evaluate of safety and efficacy of human umbilical cord- derived mesenchymal stem cells in premature
12/28/18 - Karessa - new research and development area
Karessa Pharma Holding AB has received an exclusive license from Uppsalagruppen Medical AB for development of preparations within the benzodiazepine group based on the patented transbuccal drug delivery platform. The objective is with limited contributions develop a prioritized product including preclinical phase, thereafter, finalizing...
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2019 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2019 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415